Accessibility Menu
Vext Science logo

Vext Science(OTC) VEXTF

Current Price$0.17
Market Cap$33.29MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-88%
5 Year-71%
1 Year+35%
1 Month-4%
Vext Science last closing stock price
MetricPriceDate
Last closeUSD 0.172026-07-22
Vext Science stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.61%USD 0.182026-07-15
1 month-3.65%USD 0.182026-06-22
3 month-14.08%USD 0.202026-04-23
Year to date-9.55%USD 0.192025-12-31
1 year+35.1%USD 0.132025-07-21
3 year-11.87%USD 0.202023-07-21
5 year-70.99%USD 0.592021-07-23
Since inception-87.5%USD 1.432019-05-24

Vext Science Financials at a Glance

Market Cap

$33.29MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$52.01M

Net Income (TTM)

-$15.70M

EPS (TTM)

-$0.08

P/E Ratio

-2.33

Dividend

$0.00

Beta (Volatility)

0.72 (Low)

Price

$0.17

Volume

112,500

Open

$0.17

Previous Close

$0.17

Daily Range

$0.17 - $0.18

52-Week Range

$0.10 - $0.32

Estimated Earnings Date

Aug 19, 2026

VEXTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vext Science

Vext Science, Inc. operates as a comprehensive enterprise within the United States' cannabis sector, focusing on agricultural technology, manufacturing, and distribution of THC and CBD products. Established in 2015, the company manages retail dispensaries and offers a diverse range of cannabis-derived products under its Vapen and Pure Touch Botanicals brands.

Products and Services
  • Manufactures and distributes THC and CBD products, including vape cartridges and edibles
  • Operates retail dispensaries and wholesale distribution channels
  • Offers infused edibles through the Vapen Kitchens line
Growth Outlook
  • Revenue increased to $11.99 million in Q1 2026, showing strong demand
  • Gross profit margin improved to 12.9% in Q1 2026, indicating operational efficiency
  • Inventory turnover ratio of 4.61 suggests effective inventory management
Financial Highlights
  • Trailing twelve months revenue of $54.5 million, reflecting consistent growth
  • Net income for Q1 2026 was -$879,644, showing potential for future profitability
  • Cash flow from operations reached $1.59 million in Q1 2026, supporting liquidity
Vext Science, Inc. is positioned in a rapidly growing industry, with a focus on both THC and CBD products. The company's recent revenue growth and improved gross profit margins indicate a positive trajectory. The effective management of inventory and cash flow further supports its operational capabilities. As the cannabis market continues to expand, Vext Science, Inc. may present opportunities for investors looking to engage with this dynamic sector.
AI Generated • Jul 12, 2026

Industry

Pharmaceuticals

CEO

Eric Offenberger, CPA

Headquarters

Phoenix, AZ 85019, CA

VEXTF Financials

Key Financial Metrics (TTM)

Gross Margin

23.83%

Operating Margin

-15.25%

Net Income Margin

-30.20%

Return on Equity

-25.19%

Return on Capital

-10.36%

Return on Assets

-13.36%

Earnings Yield

-42.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$33.29MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

185.79M

Volume

112.50K

Avg. Volume

32.83K

Financials (TTM)

Gross Profit

$12.39M

Operating Income

-$7.93M

EBITDA

$9.19M

Operating Cash Flow

$10.27M

Capital Expenditure

-$3.18M

Free Cash Flow

$7.09M

Cash & ST Invst.

$5.56M

Total Debt

$34.08M

Vext Science Performance Analysis

Vext Science annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 35,410,636-4.9%
20232023-12-31USD 34,812,311-1.7%
20242024-12-31USD 35,997,5813.4%
20252025-12-31USD 51,367,00042.7%
Vext Science sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3016.0%
Q32025-09-30-5.5%
Q42025-12-3110.0%
Q12026-03-31-14.0%
Vext Science annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.08129.3%
20232023-12-31USD 0.03-65.9%
20242024-12-31USD -0.09N/A
20252025-12-31USD -0.07-21.9%
Vext Science sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3054.8%
Q32025-09-30-72.1%
Q42025-12-31-449.5%
Q12026-03-3193.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$11.99M

+3.7%

Gross Profit

$1.55M

-31.9%

Gross Margin

12.94%

N/A

Market Cap

$33.29MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$192.41K

N/A

Employees

173

N/A

Net Income

-$879.64K

+73.6%

EBITDA

$2.32M

+130.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$5.56M

+15.2%

Total Debt

$34.08M

-8.8%

Accounts Receivable

$1.71M

-5.9%

Inventory

$8.60M

-17.2%

Long Term Debt

$25.68M

-22.8%

Short Term Debt

$8.38M

+103.7%

Return on Assets

-13.36%

N/A

Return on Invested Capital

-8.80%

N/A

Free Cash Flow

$1.18M

-48.0%

Operating Cash Flow

$1.59M

-48.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CXXIFC21 Investments Inc.
$0.22-0.05%
MRMDMariMed Inc.
$0.07+0.00%
LEEEFLeef Brands Inc.
$0.20-5.16%
ELIXFElixxer Ltd.
$0.03+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$23.04+0.04%
SMCISuper Micro Computer
$30.56+0.20%
AALAmerican Airlines Group
$14.79-0.03%
NOKNokia
$10.28-0.03%

Questions About VEXTF

What is the current price of Vext Science?

Vext Science is trading at $0.17 per share.

What is the 52-week range for Vext Science?

Over the past 52 weeks, Vext Science has traded between $0.10 and $0.32.

How much debt does Vext Science have?

As of the most recent reporting period, Vext Science reported total debt of $33.97M.

How much cash does Vext Science have on hand?

Vext Science reported $5.54M in cash and cash equivalents in its most recent financial results.

What is Vext Science’s dividend yield?

Vext Science does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.